{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:02:04Z","timestamp":1790899324491,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/0163"],"award-info":[{"award-number":["PI14\/0163"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Agencia de Ciencia y Tecnolog\u00eda de la Regi\u00f3n de Murcia","doi-asserted-by":"publisher","award":["19334\/PI\/14"],"award-info":[{"award-number":["19334\/PI\/14"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.yjmcc.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T12:00:14Z","timestamp":1555329614000},"page":"216-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5452-8781","authenticated-orcid":false,"given":"M.C.","family":"Asensio-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Fernandez del Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bayes-Genis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.04.009_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0010","doi-asserted-by":"crossref","first-page":"H459","DOI":"10.1152\/ajpheart.00054.2011","article-title":"Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure","volume":"301","author":"Yin","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/bmm.09.56","article-title":"ST2 protein in heart disease: from discovery to mechanisms and prognostic value","volume":"3","author":"Weinberg","year":"2009","journal-title":"Biomark. Med"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0025","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-0074","article-title":"Clinical relevance of sST2 in cardiac diseases","volume":"54","author":"Pascual-Figal","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0035","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0040","doi-asserted-by":"crossref","first-page":"70B","DOI":"10.1016\/j.amjcard.2015.01.044","article-title":"ST2 testing for chronic heart failure therapy monitoring: the international ST2 consensus panel","volume":"115","author":"Januzzi","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","article-title":"Transcription factor YY1: structure, function, and therapeutic implications in cancer biology","volume":"25","author":"Gordon","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1101\/gad.1559007","article-title":"YY1 helps to bring loose ends together","volume":"21","author":"Calame","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yjmcc.2014.10.006","article-title":"Gene reprogramming in exercise-induced cardiac hypertrophy in swine: a transcriptional genomics approach","volume":"77","author":"Kuster","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0065","doi-asserted-by":"crossref","first-page":"31233","DOI":"10.1074\/jbc.M301917200","article-title":"Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter","volume":"278","author":"Sucharov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2008.10.174","article-title":"Transcription factor Yin Yang 1 represses fetal troponin I gene expression in neonatal myocardial cells","volume":"378","author":"Nan","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/trns.1.2.12375","article-title":"Yin Yang 1: a multifaceted protein beyond a transcription factor","volume":"1","author":"Deng","year":"2010","journal-title":"Transcription."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvu122","article-title":"Chromatin modifications remodel cardiac gene expression","volume":"103","author":"Mathiyalagan","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2014.00036","article-title":"Integrated mechanisms of CaMKII-dependent ventricular remodeling","volume":"5","author":"Kreusser","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0090","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI27438","article-title":"CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy","volume":"116","author":"Backs","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.bbamcr.2008.05.015","article-title":"YY1 restrained cell senescence through repressing the transcription of p16","volume":"1783","author":"Wang","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0100","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, american college of veterinary internal medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0110","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0115","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in Vivo","volume":"279","author":"Zou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0120","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.RES.69.6.1476","article-title":"Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart","volume":"69","author":"Hescheler","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","article-title":"Properties of a clonal muscle cell line from rat heart","volume":"98","author":"Kimes","year":"1976","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0130","doi-asserted-by":"crossref","first-page":"32562","DOI":"10.1074\/jbc.M801904200","article-title":"Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase","volume":"283","author":"Stuck","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s10863-005-6635-z","article-title":"Intracellular Ca2+ pools and fluxes in cardiac muscle-derived H9c2 cells","volume":"37","author":"Lax","year":"2005","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0140","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.200108062","article-title":"PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1\/2 (ERK1\/2)","volume":"156","author":"Braz","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0145","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1074\/jbc.M111.324566","article-title":"Involvement of nuclear factor \u03baB (NF-\u03baB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression","volume":"287","author":"Islam","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2016.04.015","article-title":"Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging","volume":"97","author":"Reid","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0155","doi-asserted-by":"crossref","first-page":"P4984","DOI":"10.1093\/eurheartj\/eht310.P4984","article-title":"Development of a new model of cardiac hypertrophy with pro-arrhythmic features to study the role of hypertrophy in arrhythmogenesis","volume":"34","author":"Neshati","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0160","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1210\/en.2007-0326","article-title":"Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein","volume":"148","author":"Liu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1756-0500-5-513","article-title":"A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue","volume":"5","author":"Dimauro","year":"2012","journal-title":"BMC Res. Notes."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate Galectin-3 and Interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Hear. Fail."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0185","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3892\/mmr.2014.2051","article-title":"IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-\u03baB pathways","volume":"9","author":"Yin","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0190","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0195","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.CIR.0000127958.21003.5A","article-title":"Serum levels of the Interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction","volume":"109","author":"Shimpo","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0200","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase","volume":"119","author":"Sasaki","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cvr\/cvq066","article-title":"Metformin attenuates cardiac fibrosis by inhibiting the TGF 1-Smad3 signalling pathway","volume":"87","author":"Xiao","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183664","article-title":"A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction","volume":"12","author":"Hesen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0220","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","article-title":"Repurposing metformin for cardiovascular disease","volume":"137","author":"Rena","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes StatusNovelty and significance","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0230","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1038\/s41598-017-09189-y","article-title":"Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems","volume":"7","author":"Udhane","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 Axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2332\/allergolint.12-OA-0424","article-title":"Involvement of PU.1 in mast cell\/basophil-specific function of the human IL1RL1\/ST2 promoter","volume":"61","author":"Baba","year":"2012","journal-title":"Allergol. Int."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0245","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/eci.12282","article-title":"Modulation of IL-33\/ST2 system in post-infarction heart failure: correlation with cardiac remodeling markers","volume":"44","author":"Sanchez-Mas","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0250","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2013.07.087","article-title":"Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3","volume":"63","author":"Bayes-Genis","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jchf.2016.09.010","article-title":"Prognostic value of soluble suppression of Tumorigenicity-2 in chronic heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Hear. Fail."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0260","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","article-title":"A. Bayes-Genis, MUSIC investigators, soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction","volume":"54","author":"Pascual-Figal","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0265","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","article-title":"Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure","volume":"52","author":"Rehman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0270","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurjhf\/hfr047","article-title":"Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure","volume":"13","author":"Pascual-Figal","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0275","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20061085","article-title":"Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription","volume":"400","author":"Han","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0280","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1152\/japplphysiol.00344.2009","article-title":"Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin","volume":"107","author":"Giger","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0285","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1006\/jmcc.1996.0239","article-title":"Phorbol myristate acetate-induced hypertrophy of neonatal rat cardiac myocytes is associated with decreased sarcoplasmic reticulum Ca2+ ATPase (SERCA2) gene expression and calcium reuptake","volume":"28","author":"Hartong","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbaexp.2005.01.012","article-title":"T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3","volume":"1728","author":"Hayakawa","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0295","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.112.276915","article-title":"Ca2+\/calmodulin-dependent protein kinase II \u03b4 mediates myocardial ischemia\/reperfusion injury through nuclear factor-\u03baB","volume":"112","author":"Ling","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0300","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1536\/ihj.51.348","article-title":"BAY 11-7082, a nuclear factor-\u03baB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model","volume":"51","author":"Kim","year":"2010","journal-title":"Int. Heart J."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0305","first-page":"1765","article-title":"Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer","volume":"11","author":"Riggs","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-1119(99)00261-9","article-title":"Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?","volume":"236","author":"Thomas","year":"1999","journal-title":"Gene."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0315","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ceca.2006.07.011","article-title":"Free and bound intracellular calmodulin measurements in cardiac myocytes","volume":"41","author":"Wu","year":"2007","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0320","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2014.00036","article-title":"Integrated mechanisms of CaMKII-dependent ventricular remodeling","volume":"5","author":"Kreusser","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0325","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI27438","article-title":"CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy","volume":"116","author":"Backs","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0330","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbamcr.2006.09.029","article-title":"Nuclear Ca2+\/calmodulin-dependent protein kinase II in the murine heart","volume":"1763","author":"Li","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0335","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.140199597","article-title":"Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization","volume":"97","author":"Grozinger","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.009_bb0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-3667-0_4","article-title":"Molecular and functional characterization of histone deacetylase 4 (HDAC4)","volume":"1436","author":"Li","year":"2016","journal-title":"Methods Mol. Biol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818303961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818303961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:28:42Z","timestamp":1758313722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818303961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":68,"alternative-id":["S0022282818303961"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}